/DMAQ

DMAQ Stock - Deep Medicine Acquisition Corp.

Q: What is the analyst price target for DMAQ?

Analyst price target information is not currently available for DMAQ.

Q: What is DMAQ's market cap?

Market capitalization information is not currently available for DMAQ.

Financial Services|Shell Companies|NASDAQ

$2.96-64.72%

$5.43 (-64.72%) • Jan 31

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $3.26

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DMAQ

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.02

52W High$19.91

52W Low$2.96

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2022	FY2021
Revenue	$21.86M	N/A	N/A
Gross Profit	$14.59M	$-60,000	$-60,000
Gross Margin	66.7%	N/A	N/A
Operating Income	$-2,102,961	$-342,663	$-461,646
Net Income	$-8,795,419	$-400,232	$-358,178
Net Margin	-40.2%	N/A	N/A
EPS	$-756.01	$-0.17	$-0.04

Company Overview

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

Earnings History & Surprises

DMAQ

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.06

Q3 2023

EPS Surprise History

Q4 21

No data

Q1 22

No data

Q2 22

No data

Q3 22

No data

Q4 22

No data

Q1 23

No data

Q2 23

No data

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$-0.06	—	—
Q2 2023	Jun 30, 2023	—	$-0.06	—	—
Q1 2023	Mar 31, 2023	—	$-0.28	—	—
Q4 2022	Dec 31, 2022	—	$0.04	—	—
Q3 2022	Sep 30, 2022	—	$0.02	—	—
Q2 2022	Jun 30, 2022	—	$-0.00	—	—
Q1 2022	Mar 31, 2022	—	$-0.02	—	—
Q4 2021	Dec 31, 2021	—	$-0.01	—	—
Q3 2021	Sep 30, 2021	—	$-0.00	—	—
Q2 2021	Jun 30, 2021	—	$-0.00	—	—

Frequently Asked Questions about DMAQ

What is DMAQ's current stock price?

Deep Medicine Acquisition Corp. (DMAQ) is currently trading at $2.96 per share. The stock has moved -64.72% today.

What is the analyst price target for DMAQ?

No analyst price targets are currently available for this stock.

What sector is Deep Medicine Acquisition Corp. in?

Deep Medicine Acquisition Corp. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the NASDAQ exchange.

What is DMAQ's market cap?

Deep Medicine Acquisition Corp. has a market capitalization of $0.01 billion, making it a small-cap company.

Does DMAQ pay dividends?

No, Deep Medicine Acquisition Corp. does not currently pay a dividend to shareholders.